# EDGAR Filing Document

**Accession Number:** 0001367633
**File Stem:** 0001213900-25-081278
**Filing Date:** 2025-8
**Character Count:** 9146
**Document Hash:** 5e1ae046e19e7a40ad645f31ebe5acc4
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-081278.hdr.sgml**: 20250827

**ACCESSION NUMBER**: 0001213900-25-081278

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250814

**FILED AS OF DATE**: 20250827

**DATE AS OF CHANGE**: 20250827

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Salmasi Allen
- **CENTRAL INDEX KEY:** 0001367633

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40218
- **FILM NUMBER:** 251267088

**MAIL ADDRESS:**
- **STREET 1:** C/O NEXTWAVE WIRELESS LLC
- **STREET 2:** 12670 HIGH BLUFF DRIVE
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92130
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** NLabs Inc.
- **CENTRAL INDEX KEY:** 0002025902

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40218
- **FILM NUMBER:** 251267087

**BUSINESS ADDRESS:**
- **STREET 1:** 164 EAST 83RD STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10028
- **BUSINESS PHONE:** 2122492686

**MAIL ADDRESS:**
- **STREET 1:** 164 EAST 83RD STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10028
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** VEEA INC.
- **CENTRAL INDEX KEY:** 0001840317
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 463921281
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 164 E. 83RD STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10028
- **BUSINESS PHONE:** (212) 535-6050

**MAIL ADDRESS:**
- **STREET 1:** 164 E. 83RD STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10028

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Plum Acquisition Corp. I
- **DATE OF NAME CHANGE:** 20210113

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Salmasi Allen<br><sub>(Last) (First) (Middle)</sub><br>164 EAST 83RD STREET<br><sub>(Street)</sub><br>NEW YORK, NY 10028<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-08-14 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Chief Executive Officer_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>VEEA INC. [ VEEA ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>NLabs Inc.<br><sub>(Last) (First) (Middle)</sub><br>164 EAST 83RD STREET<br><sub>(Street)</sub><br>NEW YORK, NY 10028<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-08-14 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>VEEA INC. [ VEEA ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock<sup>(2)</sup> | 2025-08-14 |  | J<sup>(1)</sup> |  | 5239096 | A | 1<sup>(1)</sup> | 17388017 | D |  |
| Common Stock<sup>(2)</sup> | 2025-08-14 |  | J<sup>(1)</sup> |  | 5239096 | A | 1<sup>(1)</sup> | 21124580 | I | Owned by NLabs, Inc. |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Common Warrants<sup>(4)</sup> | 1.1<sup>(3)</sup> | 2025-08-14 |  | J<sup>(3)</sup> |  | 5239096 |  | 2025-08-14 | 2030-08-14 | Common Stock | 5239096 | 0.00<sup>(3)</sup> | 5239096 | D |  |
| Common Warrants<sup>(4)</sup> | 1.1<sup>(3)</sup> | 2025-08-14 |  | J<sup>(3)</sup> |  | 5239096 |  | 2025-08-14 | 2030-08-14 | Common Stock | 5239096 | 0.00<sup>(3)</sup> | 5239096 | I | Owned by NLabs, Inc. |

---

### Footnotes:

(1) Shares issued in a public best-efforts offering by the Issuer on the Registration Statement (333-288878) pursuant to Form S-1, which shares were issued at a public offering price of $1.00 per share and associated common warrant, and which warrant has an exercise price of $1.10 (subject to adjustment as provided therein).

(2) Consists of shares issued to NLabs Inc., a Delaware corporation, of which is Mr. Salmasi is the CEO and stockholder, pursuant to the above-mentioned offering. Mr. Salmasi disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

(3) Warrants issued in a public best-efforts offering by the Issuer on the Registration Statement (333-288878) pursuant to Form S-1, which warrants were issued at a public offering price of $1.00 per share and associated common warrant, and which warrant has an exercise price of $1.10 (subject to adjustment as provided therein).

(4) Consists of warrants issued to NLabs Inc., a Delaware corporation, of which is Mr. Salmasi is the CEO and stockholder, pursuant to the above-mentioned offering. Mr. Salmasi disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these warrants in this report shall not be deemed an admission of beneficial ownership of all of the reported warrants for purposes of Section 16 or for any other purpose.

**Signature:** /s/ Allen Salmasi  
**Date:** 2025-08-27

**Signature:** NLabs Inc. By: /s/ Janice K, Smith  
**Date:** 2025-08-27

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**